Related Experiment Video
Updated: Jun 24, 2026

Semi-Automatic Graphical Tool for Measuring Coronary Artery Spatially Weighted Calcium Score from Gated Cardiac Computed Tomography Images
Published on: September 22, 2023
Association between depression and coronary artery calcification in women with systemic lupus erythematosus
Carol M Greco1, Amy H Kao, Abdus Sattar
1Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. grecocm@upmc.edu
Insights
In women with Systemic Lupus Erythematosus (SLE), depression is linked to coronary artery calcification (CAC). This connection is mediated by Body Mass Index (BMI), highlighting adiposity
Area of Science:
- Rheumatology
- Cardiology
- Psychiatry
Background:
- Systemic Lupus Erythematosus (SLE) is an autoimmune disease associated with increased cardiovascular disease (CVD) risk.
- Depression is a common comorbidity in SLE patients.
- The interplay between depression, cardiovascular risk factors, and subclinical atherosclerosis in SLE requires further investigation.
Purpose of the Study:
- To investigate the association between depressive symptoms, cardiovascular risk factors, and coronary artery calcification (CAC) in women with SLE.
- To compare these associations in SLE patients versus healthy controls.
Main Methods:
- Coronary artery calcification (CAC) was quantified using electron-beam computed tomography (EBCT).
- Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CES-D).
- Data were collected from 161 women with SLE and 161 matched healthy controls, measuring traditional, inflammatory, and SLE-specific risk factors.
Main Results:
- Women with SLE reported significantly more depressive symptoms than controls (27% vs. 15%).
- SLE patients exhibited a higher prevalence and severity of CAC compared to controls.
- In SLE women, depression was independently associated with a greater than 2-fold odds of having CAC (OR 2.48), an association attenuated by Body Mass Index (BMI), suggesting BMI mediation.
Conclusions:
- Depression is significantly associated with coronary artery calcification in women with SLE.
- Body Mass Index (BMI) plays a mediating role in the relationship between depression and CAC in this population.
- Combined, depression and adiposity may exacerbate the inflammatory burden in SLE, contributing to heightened cardiovascular disease risk.
Objectives:
To determine the associations between depression, cardiovascular risk factors and coronary artery calcification (CAC) in women with SLE and controls.
Methods:
CAC was measured using electron-beam CT (EBCT). Traditional, inflammatory and lupus-related risk factors as well as depressive symptoms (Center for Epidemiologic Studies Depression Scale-CES-D) were measured at a single study visit in 161 women with SLE and 161 age- and race frequency-matched female healthy controls.
Results:
Women with SLE reported more depressive symptoms than controls, with 27% of SLE and 15% of controls having CES-D scores suggestive of clinical depression. SLE women were more likely to have CAC, as well as more severe CAC compared with controls. Among the SLE women, depression was associated with greater than 2-fold odds of having any CAC [odds ratio (OR) 2.48; 95% CI 1.05, 5.87; P = 0.04], independent of traditional risk factors (age, hypertension and triglycerides) and inflammatory markers. However, when BMI was included among the covariates, the association between depression and CAC was attenuated, indicating the potential mediating role of BMI. Depression was not a risk factor for CAC in controls.
Conclusions:
In women with SLE, depression was associated with CAC. This association was mediated by BMI. Depression and adiposity may add to the inflammatory burden of SLE, thus contributing to cardiovascular disease risk.
Related Concept Videos
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease II: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
